← Evidence map

ArticleFrontiers in oncology2026

Selinexor enhances temozolomide efficacy in glioblastoma through modulation of multiple resistance-associated mechanisms.

Beyza Ozturk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42865590